NM_033225.6:c.1562-22323A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_033225.6(CSMD1):c.1562-22323A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.7 in 152,120 control chromosomes in the GnomAD database, including 37,557 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.70 ( 37557 hom., cov: 34)
Consequence
CSMD1
NM_033225.6 intron
NM_033225.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.876
Publications
0 publications found
Genes affected
CSMD1 (HGNC:14026): (CUB and Sushi multiple domains 1) Predicted to act upstream of or within several processes, including learning or memory; mammary gland branching involved in pregnancy; and reproductive structure development. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
CSMD1 Gene-Disease associations (from GenCC):
- autism spectrum disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- complex neurodevelopmental disorderInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.742 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CSMD1 | NM_033225.6 | c.1562-22323A>G | intron_variant | Intron 12 of 69 | ENST00000635120.2 | NP_150094.5 | ||
| CSMD1 | XM_011534752.3 | c.1562-22323A>G | intron_variant | Intron 12 of 68 | XP_011533054.1 | |||
| CSMD1 | XM_017013731.2 | c.1562-22323A>G | intron_variant | Intron 12 of 63 | XP_016869220.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.700 AC: 106422AN: 152002Hom.: 37549 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
106422
AN:
152002
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.700 AC: 106472AN: 152120Hom.: 37557 Cov.: 34 AF XY: 0.699 AC XY: 51997AN XY: 74376 show subpopulations
GnomAD4 genome
AF:
AC:
106472
AN:
152120
Hom.:
Cov.:
34
AF XY:
AC XY:
51997
AN XY:
74376
show subpopulations
African (AFR)
AF:
AC:
25339
AN:
41482
American (AMR)
AF:
AC:
11409
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
2804
AN:
3472
East Asian (EAS)
AF:
AC:
2686
AN:
5158
South Asian (SAS)
AF:
AC:
3678
AN:
4826
European-Finnish (FIN)
AF:
AC:
7787
AN:
10582
Middle Eastern (MID)
AF:
AC:
204
AN:
294
European-Non Finnish (NFE)
AF:
AC:
50336
AN:
68002
Other (OTH)
AF:
AC:
1490
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1651
3302
4954
6605
8256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
834
1668
2502
3336
4170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2198
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.